Charles W.M. Roberts – Candidate for Board of Directors of AACR
OncoDaily GU · Lycoming Career and Technology Center, PA · 2 days ago
Business DevelopmentVolunteer
About the role
The voting for the 2025 AACR Annual Election is now open, where members will vote for the next President-Elect, Treasurer, five Board Members, and four members of the Nominating Committee. This year, Charles W.M. Roberts, MD, PhD is a candidate for the Board of Directors of AACR.
Responsibilities
- Serves as a member of the Steering Committee for the Hematologic Malignancies Working Group
- Co-chairs the Special Conferences Committee
- Serves as a member of the Annual Meeting Program Committee (2016-2017 and 2023-2024)
- Serves as a member of the Annual Meeting Education Committee (2016-2017)
- Serves as a member of the Scientific Review Committee for Basic Cancer Research Grants (2014-2016)
- Co-chairs the Special Conferences Committee
- Serves as a member of the Pediatric Cancer Working Group Steering Committee (2020-2023)
- Contributes to AACR publications as a scientific editor for Cancer Discovery (since 2020) and as a member of the editorial board for Molecular Cancer Research (since 2015)
Requirements
Dr. Charles W. M. Roberts is highly engaged with AACR through numerous leadership roles and contributions. He has a strong background in pediatric oncology, molecular oncology, and epigenetics, with extensive experience in research, teaching, and clinical practice.
Qualifications
- Cancer Center Director and Executive Vice President at St. Jude Comprehensive Cancer Center
- Lillian R. Cannon Comprehensive Cancer Center Director Endowed Chair
- Attending physician in the Department of Oncology at St. Jude Children’s Research Hospital
- Professor in the Department of Pathology and Laboratory Medicine at the University of Tennessee Health Science Center
- Formerly held key positions at Dana-Farber Cancer Institute, including Deputy Chief Scientific Officer (2015), Scientific Director, and Co-Director of the Pediatric Solid Tumor Disease Center (2007-2015)
- Contributed to the development of Tazemetostat, a first-in-class targeted epigenetic regulator
Skills
- Research in pediatric oncology and epigenetics
- Leadership roles in AACR
- Expertise in molecular and epigenetic mechanisms of cancer
- Experience in translational and clinical research
Benefits
Not specified.
Pay
Not specified.
Schedule
Not specified.